National Comprehensive Cancer Network

Subscriptions & Products
For Patients
NCCN Compendium™
About the NCCN Compendium™
NCCN Compendium™ Chapters
Summary of Updates
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines™ & Clinical Resources

NCCN 3rd Annual Congress Hematologic Malignancies Program Overview

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend


Go back to previous page

 

 

     
 

Program Overview

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring new benefits to patients. This program will focus on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Last update 03/17/2008.